✦ LIBER ✦

Dopamine, 6-hydroxydopamine, iron, and dioxygen — their mutual interactions and possible implication in the development of Parkinson's disease

✍ Scribed by Wolfgang Linert; Erwin Herlinger; Reginald F. Jameson; Elizabeth Kienzl; Kurt Jellinger; Moussa B.H. Youdim

Book ID: 116160017
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 736 KB
Volume: 1316
Category: Article
ISSN: 0925-4439
DOI: 10.1016/0925-4439(96)00020-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

GRAPE SEED PROANTHOCYANIDIN EXTRACT CHEL

GRAPE SEED PROANTHOCYANIDIN EXTRACT CHELATES IRON AND ATTENUATES THE TOXIC EFFECTS OF 6-HYDROXYDOPAMINE: IMPLICATIONS FOR PARKINSON'S DISEASE

✍ TZU-HUA WU; JIAHN-HAUR LIAO; FENG-LIN HSU; HUEY-RU WU; CHUAN-KUO SHEN; JEU-MING 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

The vesamicol receptor ligand (+)-meta-[

The vesamicol receptor ligand (+)-meta-[1251]iodobenzyltrozamicol {(+)-[125¦]-MIBT} reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: Possible implications for parkinson's disease

✍ Simon M.N. Efange; Rosemary B. Langason; Anil B. Khare; Walter C. Low 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 666 KB

Role of dopamine D3and serotonin 5-HT1Ar

Role of dopamine D3and serotonin 5-HT1Areceptors inl-DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson’s disease

✍ Manfred Gerlach; Gerd D. Bartoszyk; Peter Riederer; Olivia Dean; Maarten van den 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 284 KB

Chronic treatment with the mGlu5R antago

Chronic treatment with the mGlu5R antagonist MPEP reduces the functional effects of the mGlu5R agonist CHPG in the striatum of 6-hydroxydopamine-lesioned rats: Possible relevance to the effects of mGlu5R blockade in Parkinson's disease

✍ Maria Rosaria Domenici; Rosa Luisa Potenza; Alberto Martire; Roberto Coccurello; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

## Abstract This study was designed to test whether chronic treatment with the metabotropic glutamate receptor 5 (mGlu5R) antagonist MPEP showed antiparkinsonian effects in rats unilaterally lesioned with 6‐hydroxydopamine (6‐OHDA) (a “classic” model of Parkinson's disease, PD), and to evaluate whe